ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Ibrutinib Improves Outcomes in CLL/SLL

Ibrutinib Improves Outcomes in CLL/SLL

In this video, Asher A. Chanan-Khan, MD, of the Mayo Clinic in Jacksonville, Florida, discusses a phase III trial of ibrutinib in combination with bendamustine and rituximab in patients with previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

The trial’s results (abstract LBA7005) were presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting held May 29–June 2 in Chicago.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.